Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Therapy or antidepressants? Coming soon: Brain activity “fingerprints” to personalize depression treatments

mental health.

To Treat Depres­sion, Drugs or Ther­apy? (The New York Times):

Until recently, many experts thought that your clin­i­cian could lit­er­ally pick any anti­de­pres­sant or type of psy­chother­apy at ran­dom because, with a few clin­i­cal excep­tions, there was lit­tle evi­dence to favor one treat­ment over another for a given patient Read the rest of this entry »

The New York Times starts to pay attention: Exercising The Mind to Treat Attention Deficits

mind_childExer­cis­ing The Mind to Treat Atten­tion Deficits (The New York Times):

Poor plan­ning, wan­der­ing atten­tion and trou­ble inhibit­ing impulses all sig­nify lapses in cog­ni­tive con­trol. Now a grow­ing stream of research sug­gests that strength­en­ing this men­tal mus­cle, usu­ally with exer­cises in Read the rest of this entry »

Upcoming Webinar: The Digital Brain Health & Training Market in 2014

Webinar digital brain health & trainingWhen: Thurs­day, March 13, 2014 from 12:30 PM to 2:00 PM (EDT)

Join this upcom­ing webi­nar, to be held dur­ing Brain Aware­ness Week 2014, to dis­cuss the lat­est mar­ket data and news in the dig­i­tal brain health and brain train­ing space, includ­ing Rosetta Stone’s acqui­si­tion of Viv­ity Labs (devel­oper of Fit Brains mobile cog­ni­tive games), Bayer’s global part­ner­ship with Cog­niFit Read the rest of this entry »

Update: A Fresh Look at Enhancing Brain & Mental Health Across the Lifespan

kid brainTime for Sharp­Brains’ May 2013 e-newsletter, which fea­tures a vari­ety of arti­cles offer­ing a more opti­mistic and evidence-based approach to brain and men­tal health than cur­rent practices.

First of all, let us high­light that Sci­en­tific Amer­i­can just pub­lished an excel­lent review of our new book. The author sums it up by say­ing that “…I wish I had read this awe­some guide when I was much younger…I find the emerg­ing field of neu­ro­plas­tic­ity immensely excit­ing, and guides like this one are both hope­ful and rea­son­able.” As a reader points out, the word “awe­some” does not appear often in science-oriented publications…so we are espe­cially proud to see the book merit such treatment.

New think­ing:

New sci­ence:

New tools:

That’s it for now. Have a stim­u­lat­ing June!

Challenging medical dogma: Mental exercise vs drugs, supplements and physical exercise to prevent cognitive decline

Brain ThinkerMen­tal exer­cises may pre­vent men­tal decline in seniors (CBC News):  “A review released by the Cana­dian Med­ical Asso­ci­a­tion Jour­nal on the pre­ven­tion of cog­ni­tive decline said that med­i­c­i­nal and non-medicinal prod­ucts, and phys­i­cal exer­cise did noth­ing to pre­vent the decline in healthy seniors, but men­tal exer­cises Read the rest of this entry »

Drugs for Early-Stage Alzheimer’s?

Medical-warning-label-concept--42312982Drugs for Early-Stage Alzheimer’s (good New York Times editorial):

The Food and Drug Admin­is­tra­tion has pro­posed low­er­ing the bar for approv­ing drugs to treat peo­ple at the ear­li­est stages of Alzheimer’s dis­ease, before they have devel­oped any seri­ous impair­ment or overt demen­tia. The goal is com­mend­able — to find ways to pre­vent or slow the pro­gres­sion of this ter­ri­ble dis­ease before it can rob peo­ple of their men­tal capac­i­ties. But the pro­posal raises trou­bling ques­tions as to whether the agency would end up approv­ing drugs that pro­vide lit­tle or no clin­i­cal ben­e­fit yet Read the rest of this entry »

Neurologists prescribing cognitive enhancement drugs to healthy kids and adults?

Human-brain-pillsAccord­ing to a new posi­tion state­ment by the Amer­i­can Acad­emy of Neu­rol­ogy (AAN), pre­scrib­ing cog­ni­tive enhance­ment, “attention-boosting,” drugs to healthy chil­dren is mis­guided and not jus­ti­fi­able. Inter­est­ingly, a 2009 posi­tion state­ment by AAN still in force today stated that doing so with adult “patients” is both legal and eth­i­cal (includ­ing the remark that “Neu­rol­o­gists who pre­scribe med­ica­tions for the off-label use of neu­roen­hance­ment are act­ing law­fully,” with­out really chal­leng­ing whether the drugs have been proven to be a) effec­tive and b) safe in that con­text). Read the rest of this entry »

Welcome to

As seen in The New York Times, The Wall Street Journal, CNN,, and more, SharpBrains is an independent market research firm tracking health and wellness applications of brain science. Explore our most popular resources HERE.

Haven’t you read this book yet?

Follow Us…


Newsletter Signup

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:
Join more than 50,000 Sub­scribers and stay informed and engaged.

Subscribe RSS Feed

Subscribe to the RSS Feed